Market
What will be the global market approval status of the new injection by the end of 2025?
2
Resolution / Starting Odds
Approved in UK only • 25%
Approved in UK and EU • 25%
Approved in UK, EU, and USA • 25%
Not approved in any major market • 25%
Official announcements from regulatory agencies such as the FDA, EMA, and MHRA
Story
UK Scientists Develop First Game-Changing Injection for Asthma and COPD Treatment, Reducing Further Treatment Needs by 30%
Dec 2, 2024, 12:53 PM
UK scientists have developed a new injection that represents the first major advancement in asthma treatment in 50 years. This innovative therapy has been shown to be more effective than traditional steroid tablets, reducing the need for additional treatments by 30%, according to a recent study. The injection is expected to significantly change the management of asthma and Chronic Obstructive Pulmonary Disease (COPD), marking a pivotal moment in respiratory care.
View original story
Similar markets
Approved in both USA and EU • 25%
Approved in USA only • 25%
Approved in EU only • 25%
Not approved in USA or EU • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
0-5 countries • 25%
More than 15 countries • 25%
11-15 countries • 25%
6-10 countries • 25%
Approved in both US and EU • 25%
Not approved in US or EU • 25%
Approved in US • 25%
Approved in EU • 25%
Approved in other major markets • 25%
Approved in the USA • 25%
Approved in the EU • 25%
Not approved in any major market • 25%
Approved in both • 25%
Approved in EU • 25%
Approved in US • 25%
Not approved • 25%
United Kingdom • 25%
Other • 25%
European Union • 25%
Australia • 25%
